Your Article Summary
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial
The Lancet - Early Online Publication, 06/30/09
King TE et al. - The authors cannot recommend treatment with interferon gamma-1b since the drug did not improve survival for patients with idiopathic pulmonary fibrosis, which refutes previous findings from subgroup analyses of survival in studies of patients with mild-to-moderate physiological impairment of pulmonary function.
Related Articles
Tumor necrosis factor inhibitors and lung disease: A paradox of efficacy and risk
Seminars in Arthritis and Rheumatism, 11/20/09
Relevance Score: 68%
Targeted Injury of Type II Alveolar Epithelial Cells Induces Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine, 10/28/09
Relevance Score: 68%
Evaluation of recently validated non- invasive formula using basic lung functions as new screening tool for pulmonary hypertension in idiopathic pulmonary fibrosis patients
Annals of Thoracic Medicine, 10/02/09
Relevance Score: 68%
The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis
Journal of Leukocyte Biology, 11/11/09
Relevance Score: 67%
Pulmonary nocardiosis in cystic fibrosis
Journal of Cystic Fibrosis, 10/07/09
Relevance Score: 67%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Oral Immunotherapy with inactivated NTHi reduces severity of acute exacerbations in severe COPD
Chest, 12/16/09
Use of oseltamivir in children
Canadian Family Physician, 12/16/09
Measuring exacerbations in obstructive lung disease
Pharmacoepidemiology and Drug Safety, 12/16/09
Today in Cystic Fibrosis...keeping you current
Receive free subspecialty "5-minute updates" via email
Modulation of endocytic trafficking and apical stability of CFTR in primary human airway epithelial cultures
Lung Cellular and Molecular Physiology, 12/16/09
Bone mineral and body composition alterations in paediatric cystic fibrosis patients
Pediatric Radiology, 12/15/09
Decreased Levels of Secretory Leucoprotease Inhibitor in the Pseudomonas-Infected Cystic Fibrosis Lung Are Due to Neutrophil Elastase Degradation
Journal of Immunology, 12/15/09

See Latest Articles